Volume 101, Issue 4 pp. 728-736

Novel enzymatic abnormalities in AML and CML in blast crisis: elevated leucocyte leukotriene C4 synthase activity paralleled by deficient leukotriene biosynthesis from endogenous substrate

Leif Stenke

Leif Stenke

Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics,

Division of Haematology, Department of Medicine, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden

Search for more papers by this author
Mikael Sjölinder

Mikael Sjölinder

Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics,

Search for more papers by this author
Thomas D. Miale

Thomas D. Miale

Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics,

Search for more papers by this author
Jan Åke Lindgren

Jan Åke Lindgren

Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics,

Search for more papers by this author
First published: 25 December 2001
Citations: 12
Dr LeifStenke Division of Physiological Chemistry II, Department of Medical Biochemistry and Biophysics, Doktorsringen 9, Karolinska Institutet, S-171 77 Stockholm, Sweden.

Abstract

Leukotrienes (LT) are inflammatory mediators which can also exert regulatory effects on human myelopoiesis. We have studied the LT-producing capacity of freshly isolated leucocyte suspensions (containing blast cells in variable proportions) from 41 patients with acute myeloid leukaemia (AML) or chronic myeloid leukaemia (CML) in blast crisis (CMLbc) at diagnosis or relapse/resistant disease. Leucocyte suspensions from 19/29 AML patients (66%), and 2/12 CMLbc patients (17%; P = 0.012) demonstrated deficient capacity to synthesize LT from endogenous substrate after ionophore A23187 stimulation. Thus, these cells produced < 8 pmol LTB4 + LTC4/106 cells (< 20% of mean LT formation in leucocyte suspensions from 18 healthy subjects). Addition of exogenous arachidonic acid did not normalize the LT synthesis in poor-producing cell suspensions. Purified, morphologically mature granulocytes from two AML patients also failed to produce normal amounts of LT. In leucocyte suspensions from the remaining 20 AML/CMLbc patients A23187 provoked LT biosynthesis, with markedly increased production of LTC4, but decreased LTB4 formation. Furthermore, elevated conversion of exogenous LTA4 to LTC4 was noted in the patient samples, independent of their capacity to produce LT after A23187 stimulation. The percentage of blast cells in patient white blood cell differential counts correlated inversely with ionophore-induced LT synthesis, but positively with the conversion of exogenous LTA4 to LTC4. The results suggest elevated LTC4 synthase activity and suppressed 5-lipoxygenase activity as novel enzymatic features of myeloid leukaemia patients with immature phenotype.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.